1. DSpace at Riga Stradiņš University
  2. Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure
  3. Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure
Please use this identifier to cite or link to this item: 10.3390/ijerph13121194
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKovalchuka, Lilija-
dc.contributor.authorCvetkova, Svetlana-
dc.contributor.authorTrofimova, Julija-
dc.contributor.authorEglite, Jelena-
dc.contributor.authorGintere, Sandra-
dc.contributor.authorLucenko, Irina-
dc.contributor.authorOczko-Grzesik, Barbara-
dc.contributor.authorViksna, Ludmila-
dc.contributor.authorKrumina, Angelika-
dc.date.accessioned2021-04-20T13:25:02Z-
dc.date.available2021-04-20T13:25:02Z-
dc.date.issued2016-12-01-
dc.identifier.citationKovalchuka , L , Cvetkova , S , Trofimova , J , Eglite , J , Gintere , S , Lucenko , I , Oczko-Grzesik , B , Viksna , L & Krumina , A 2016 , ' Immunogenetic markers definition in latvian patients with lyme borreliosis and lyme neuroborreliosis ' , International Journal of Environmental Research and Public Health , vol. 13 , no. 12 , 1194 . https://doi.org/10.3390/ijerph13121194-
dc.identifier.issn1661-7827-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/3871-
dc.descriptionFunding Information: This work was supported by the European Social Fund (ESF) project ?Support for doctoral study program and scientific degree receiving in Riga Stradi?? University, agreement No. 2009/0147/1DP/1.1.2.1.2/09/IPIA/VIAA/009?. Publisher Copyright: © 2016 by the authors; licensee MDPI, Basel, Switzerland. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.-
dc.description.abstractThe aim of this study was to determine the human leukocyte antigen (HLA)-DRB1 alleles in two groups of patients in Latvia: patients with Lyme borreliosis and patients with Lyme neuroborreliosis. The study included 216 patients with Lyme borreliosis, 29 patients with Lyme neuroborreliosis and 282 control persons. All surveyed persons were residents of Latvia. The HLA-DR genotyping was performed by polymerase chain reaction-sequence specific primer (PCR-SSP). The predisposition to the Lyme borreliosis is associated with the HLA-DRB1*07, -DRB1*17(03), -DRB1*04, -DRB1*15(02) alleles. The allele -DRB1*11(05), -DRB1*14(06) and -DRB1*13(06) were significantly more frequent in controls. In-group with Lyme neuroborreliosis differences were found for the -DRB1*07 and -DRB1*04 alleles, but only HLA-DRB1*07 allele was statistically significant after Bonferroni correction and associated with Lyme neuroborreliosis in Latvian patients.en
dc.format.extent312574-
dc.language.isoeng-
dc.relation.ispartofInternational Journal of Environmental Research and Public Health-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectBorrelia burgdorferi-
dc.subjectHLA-DRB1-
dc.subjectImmunogenetic markers-
dc.subjectLyme borreliosis-
dc.subjectLyme neuroborreliosis-
dc.subject3.3 Health sciences-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.subjectPublic Health, Environmental and Occupational Health-
dc.subjectHealth, Toxicology and Mutagenesis-
dc.subjectSDG 3 - Good Health and Well-being-
dc.titleImmunogenetic markers definition in latvian patients with lyme borreliosis and lyme neuroborreliosisen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article-
dc.identifier.doi10.3390/ijerph13121194-
dc.contributor.institutionJoint Laboratory of Clinical Immunology and Immunogenetics-
dc.contributor.institutionDepartment of Family Medicine-
dc.contributor.institutionDepartment of Infectology-
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85003634558&partnerID=8YFLogxK-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Immunogenetic_Markers_Definition_in_Latvian_Patients.pdf305.25 kBAdobe PDFView/Openopen_acces_unlocked
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.